New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 19, 2012
13:48 EDTSCLNGL Partners reports 6.0% stake in SciClone
News For SCLN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 27, 2015
08:16 EDTSCLNSciClone and Theravance Biopharma sign antibiotic development agreement in China
SciClone (SCLN) and Theravance Biopharma (TBPH) have entered into a development and commercialization agreement granting SciClone exclusive development and commercial rights for the antibiotic Vibativ in China and certain adjacent territories. The companies plan to pursue development and commercialization of Vibativ in hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Theravance Biopharma has granted SciClone exclusive development and commercialization rights to Vibativ in China, as well as the Hong Kong SAR, the Macau SAR, Taiwan and Vietnam. In exchange, Theravance Biopharma will be eligible to receive upfront and regulatory milestone payments totaling $6M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use